Lawyers and Settlements
Advertisement
Home Page >> Hot Legal Issues >> Johnson & Johnson Gynecare Mesh

Johnson & Johnson Gynecare Transvaginal Mesh

Were you looking for AMS Transvaginal Mesh or Avaulta or Transvaginal Mesh Side Effects lawsuits?

Johnson & Johnson has about 33,000 Gynecare lawsuits filed against its Ethicon division alleging Gynecare transvaginal mesh is defective. Rather than relieve women with Pelvic Organ Prolapse and Urinary Stress Incontinence, Gynecare Mesh side effects include severe pain, bleeding and infection. Some of the first transvaginal mesh or bladder sling products introduced in the US were made by Gynecare or Ethicon, which are subsidiaries of Johnson & Johnson.

FREE CASE EVALUATION

Send your Gynecare Mesh claim to a lawyer who will review your claim at NO COST or obligation.Get Legal Help NowNational Center for Life and Liberty
Advertisement

As of mid-December, 2014, court records indicated more than 67,500 claims had been filed against several transvaginal mesh manufacturers, including Ethicon. Gynecare pelvic mesh lawsuits allege that the mesh causes soft tissue injury, tissue erosion, bleeding, pain and infection. Plaintiffs also reported that pelvic prolapse and urinary incontinence conditions worsened after being implanted with the mesh. Many women have undergone surgery to have the mesh removed. Further, Ethicon lawsuits allege that the manufacturer knew its mesh products were unreasonably dangerous but continued to manufacture and sell them.

A study published in the Journal of the American College of Obstetricians and Gynecologists (August 2010) determined that the rate of vaginal mesh erosion with Gynecare Prolift pelvic mesh was 15.6 percent. The researchers questioned the value of Ethicon Gynecare Prolift mesh for vaginal prolapse repairs. Researchers in a study published in Obstetrics and Gynecology (September 13, 2013)indicated that the use of vaginal mesh does not increase a woman' chance of a good outcome for surgical prolapse repair when compared to more traditional treatments. Further, researchers raised the question as to whether the benefits outweighed the risk.

Gynecare Side Effects and the FDA

gynecare_mesh The first Gynecare product, Gynemesh, was introduced in late 2002. Ethicon introduced the Gynecare Prolift onto the market in March 2005, after Johnson & Johnson had it cleared by the FDA' 501(k) method. This "fast track"method means that the device did not require the usual in-depth testing and clinical trials typically required by the FDA because a similar device (Gynemesh) had already been approved. Variations of Gynecare Prolift+M were introduced in May 2008.

2008: Three years after Gynecare' approval, the FDA issues a Public Health Notification after receiving more than 1,000 reports of transvaginal mesh side effects, but says that these side effects are "rare".

July 2011: The FDA updates its 2008 notification, stating that Gynecare side effects are "not rare". Almost 3,000 women had reported complications, most of which, along with severe pain, involved mesh erosion, organ perforation, pain during sexual intercourse, and urinary problems.

January 2012: The FDA orders the makers of transvaginal surgical mesh products to study the risks associated with the products.

June 2012: Johnson & Johnson pulls four Ethicon Gyencare mesh products from the market: Gynecare TVT Secur system, the Gynecare Prosima, the Gynecare Prolift and the Gynecare Prolift+M.

April 2014: The FDA proposes new regulations that would classify transvaginal mesh devices as "high risk". Manufacturers would be required to submit the mesh devices for rigorous safety testing prior to receiving market clearance rather than fast track the product to market via the 501(k) process.

Ethicon Gynecare Lawsuits

2008: Ethicon and C.R. Bard (Avaulta product) transvaginal mesh lawsuits are pending in litigations in Bergen County after the FDA health alert.

February 2014: A Texas woman in November, 2009 was implanted with a Gynecare TVT pelvic mesh device made by Johnson & Johnson. Carolyn Lewis sues the giant drug company and her case is transferred into the MDL, where it is chosen as the first bellwether trial. The trial ends in a defense verdict after Judge Goodwin finds that the plaintiff failed to present sufficient evidence that the pelvic mesh was defectively designed or caused her to suffer an injury. Further, Ethicon says Lewis' lawsuit was untimely because her cause of action accrued no later than January or February 2010, and she filed her lawsuit in July 2012.

More than 11,000 Ethicon Gynecare mesh cases have now been filed throughout the federal court system, and consolidated before U.S. District Judge Joseph Goodwin in the Southern District of West Virginia, where the lawsuits are centralized as part of Multidistrict Litigation, or MDL.

September 2014: In the second Ethicon trial case to go to trial amongst thousands consolidated in West Virginia federal court, a jury awards Jo Huskey $3.27 million in one of 33,000 lawsuits that claim Ethicon sold defective transvaginal mesh devices, according to Reuters. Jurors found Ethicon liable for selling faulty devices and failing to warn patients and their doctors that users were at risk from side effects that include pain, bleeding and infection. The jury's award also includes $200,000 to Huskey's husband for loss of consortium. The case is Huskey v. Ethicon, U.S. District Court for the Southern District of West Virginia, No. 12-5201.

December 2014: Judge Goodwin is currently presiding over seven different federal MDLs established for similar cases filed against various medical device manufacturers, including 21,700 Ethicon mesh lawsuits. As part of the coordinated pretrial proceedings Judge Goodwin orders that groups of cases against a number of mesh manufacturers be prepared for early trial dates, or bellwether cases.

January 2015: Hundreds more vaginal mesh cases are expected to be "trial ready". If both parties do not reach agreements to resolve large amounts of cases, Judge Goodwin may start to remand claims back to the US District Courts where they were originally filed for trials. Conferences are scheduled for conferences scheduled for February 5, 2015 to discuss transavaginal mesh lawsuits involving products manufactured by Bard (Avaulta) and Ethicon.

Johnson & Johnson's Gynecare Mesh Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a Medical Device lawyer who may evaluate your claim at no cost or obligation.
Please click here for a free evaluation of your Gynecare Mesh claim
National Center for Life and Liberty
Advertisement

Last updated on

GYNECARE MESH LEGAL ARTICLES AND INTERVIEWS

$11.1M Ethicon Vaginal Mesh Settlement Upheld on Appeal
$11.1M Ethicon Vaginal Mesh Settlement Upheld on Appeal
April 1, 2016
Santa Clara, CA: An $11.1 million verdict in a Johnson & Johnson (J&J) vaginal mesh lawsuit has been upheld in appeals. It is the first bellwether trial alleging personal injury from Gynecare pelvic mesh implants made by J&J’s subsidiary Ethicon Inc.[READ MORE]

J&J Admits Destroying Vaginal Mesh Data
J&J Admits Destroying Vaginal Mesh Data
February 7, 2014
Charleston, WV Johnson& Johnson, the maker of defective vaginal mesh implants and which are the subject of numerous defective products lawsuits, has been found to have improperly destroyed files related to the products. The finding was handed down by U.S. magistrate judge Cheryl Eifert, who is presiding over the Charleston, W. Va., court where defective vaginal mesh lawsuits have been consolidated [READ MORE]

Gynecare TVM and the FDA As Hall Monitor
Gynecare TVM and the FDA As Hall Monitor
July 9, 2013
Washington, DC The parents are never home and the kids are running wild. While this would be good for a laugh in a sitcom (and probably already has, at one time), the premise as a real-life event is fraught with risk and a source of much trouble. A disaster waiting to happen [READ MORE]



READER COMMENTS

Posted by
Dakeys
on
Former FDA commissioner Margaret Hamburg named in massive conspiracy and racketeering lawsuit involving Johnson & Johnson, a Wall Street hedge fund, and the Levaquin drug_
(NaturalNews) The former head of the FDA, Margaret Hamburg, used the federal agency to run a massive conspiracy of racketeering and fraud in order to generate millions of dollars in drug company profits for her husband's hedge fund firm, alleges a damning lawsuit filed in the United States District Court for the District of Columbia.

The lawsuit alleges that while acting as FDA commissioner, Margaret Hamburg engaged in a wide-ranging conspiracy to approve an extremely dangerous drug known to cause severe (and even deadly) side effects, in order to financially benefit her husband's hedge fund which held very large financial positions in Johnson & Johnson, makers of the drug. "Defendants, each and every one of them, operated a criminal conspiracy at least between the years 2009 to 2015 to fraudulently suppress warnings about the devastating effects of Levaquin," says the complaint.

"This Amended Complaint sets forth allegations that involve a conspiracy by Defendants, each and every one of them, to reap large financial returns by failing to disclose to Plaintiffs and the public at large the full extent of the devastating, life-threatening, and deadly effects of a highly dangerous pharmaceutical drug named Levaquin," reads the opening of the lawsuit. The conspiracy complaint also alleges that over 5,000 people died as a result of Hamburg's conspiracy cover-up at the FDA:

Once confirmed as FDA Commissioner, Dr. Margaret A. Hamburg acted as the instrumentality that all Defendants used to perpetrate their conspiracy and racketeering enterprise by having her act illegally and outside the scope of her authority as FDA Commissioner to suppress material information to Plaintiffs and the public that Levaquin was inherently dangerous and in fact, deadly. Had this information been disclosed to Plaintiffs and the public at large, her and her husband's financial gain and net worth would have plummeted, since Dr. Margaret A. Hamburg's husband, Peter F. Brown, reaped and continues to reap huge financial gain as a result of Renaissance Technologies, L.L.C.'s holdings of Johnson & Johnson stock.

To further this conspiracy, Dr. Margaret A. Hamburg, acting in concert with each and every Defendant, jointly and severally, appointed officials of Johnson & Johnson to key FDA Advisory Committees and colluded with Johnson & Johnson and its officials and subsidiaries to suppress information about the dangerous and deadly effects of Levaquin. As a result, during Dr. Margaret A. Hamburg's tenure as FDA Commissioner from 2009 to 2015, over 5,000 people died as a result of consuming Levaquin and other dangerous drugs promoted, manufactured, marketed, distributed and sold by Johnson & Johnson, suffered debilitating, life-threatening, and deadly illnesses and effects. This deadly harm is continuing as Plaintiffs and thousands of other people are suffering and dying from the highly dangerous effects of Levaquin.

"Both Alkermes and Johnson & Johnson stock value increased significantly during Hamburg's tenure," reports The Daily Caller.

Margaret Hamburg "bought" her way into the FDA with financial contributions to Hillary Clinton and Barack Obama, alleges the lawsuit

A fascinating finding in the lawsuit alleges that Margaret Hamburg bribed her way into the top position at the FDA by making large financial contributions to Hillary Clinton and Barack Obama:

Dr. Margaret A. Hamburg was nominated as a result of huge political and other gratuities to Hillary Clinton and The Clinton Foundation, and at Mrs. Clinton's recommendation. During the confirmation process before Congress, Dr. Margaret A. Hamburg, acting in concert with her husband, Peter F. Brown and the other Defendants named in this Amended Complaint, at all material times the Co-CEO of a hedge fund named Renaissance Technologies, L.L.C., failed to disclose to Congress and other relevant authorities, her and her husband's clear-cut conflict of interest – specifically, that Renaissance Technologies, L.L.C. held hundreds of millions of dollars of Johnson & Johnson stock, the manufacturer of the deadly drug, Levaquin.

...Defendant Hamburg, on behalf of all of the Defendants as part of this racketeering conspiracy, gave political contributions and gratuities to Hillary Clinton in 2005, 2006, 2007, and 2008 to induce Mrs. Clinton to recommend and push for Defendant Hamburg to be nominated by President Obama.

...Defendant Hamburg, on behalf of all of the Defendants as part of this racketeering conspiracy, gave political contributions and gratuities to President Obama to induce him to nominate her to be appointed as FDA Commissioner.

From what we now know about the Clinton Foundation's deep financial ties to Big Pharma and Wall Street hedge funds, none of this comes as any sort of surprise. In fact, while these allegations may have been easily dismissed as a "conspiracy theory" in 2008, so much more awakening has happened among the American public that they are now likely to be understood as an "actual conspiracy" being carried out among the political and financial elite who routinely conspire against the people in order to enrich themselves.

Horrible side effects from the drug destroyed the lives of countless victims

From the lawsuit:

From May 2009 to March 2015, Plaintiffs suffered mitochondrial toxicity, neuropsychiatric adverse events, and multi-system disability related to their consumption of Levaquin, including a constellation of medical issues related to the following body systems: neuromuscular, neuropsychiatric, peripheral neuropathy, senses, skin, cardiovascular, plus, endocrine, nutritional, metabolic and immunity; blood and blood forming organs; circulatory system; respiratory system; digestive system; genitourinary system; and connective tissue.

Specifically, Plaintiffs suffer from a constellation of medical issues, including but not limited to widespread bodily pain, fatigue, muscle weakness, muscle twitching, muscle wasting, gait disturbances, severe balance issues, stiffness, spasms, joint pain, tendon issues, seizures, tremors, numbness, burning, tingling, fasciculation, spasticity, nerve damage, autonomic issues, voice issues, exercise intolerance, difficulty swallowing, slow digestive motility, abdominal pain, acid reflux, gastritis, nausea, constipation, diarrhea, colitis, cognitive impairment, memory impairment, cardiac issues, urinary issues, kidney damage, liver damage, pancreatic damage, thyroid abnormalities, hair loss, glucose issues, respiratory issues, emotional issues, depression, psychosis, depersonalization, dissociation, anxiety, insomnia, abnormal dreams, suicidal thoughts, thought alterations, agitation, fatigue, dizziness, inability to concentrate, panic attacks, difficulty communicating, forgetfulness, bruising, vision issues, hearing issues, tinnitus, dental issues, gum issues, skin issues, rashes, multiple chemical sensitivity, sexual dysfunction, reproductive issues, and DNA damage.

Highlights of the complaint

You can read the complaint here, posted by the Daily Caller News Foundation. I've extracted some of the highlights of the complaint for reference, shown below.

This Amended Complaint sets forth allegations that involve a conspiracy by Defendants, each and every one of them, to reap large financial returns by failing to disclose to Plaintiffs and the public at large the full extent of the devastating, life-threatening, and deadly effects of a highly dangerous pharmaceutical drug named Levaquin.

Dr. Margaret A. Hamburg was nominated as a result of huge political and other gratuities to Hillary Clinton and The Clinton Foundation, and at Mrs. Clinton's recommendation. During the confirmation process before Congress, Dr. Margaret A. Hamburg, acting in concert with her husband, Peter F. Brown and the other Defendants named in this Amended Complaint, at all material times the Co-CEO of a hedge fund named Renaissance Technologies, L.L.C., failed to disclose to Congress and other relevant authorities, her and her husband's clear-cut conflict of interest – specifically, that Renaissance Technologies, L.L.C. held hundreds of millions of dollars of Johnson & Johnson stock, the manufacturer of the deadly drug, Levaquin.

Once confirmed as FDA Commissioner, Dr. Margaret A. Hamburg acted as the instrumentality that all Defendants used to perpetrate their conspiracy and racketeering enterprise by having her act illegally and outside the scope of her authority as FDA Commissioner to suppress material information to Plaintiffs and the public that Levaquin was inherently dangerous and in fact, deadly. Had this information been disclosed to Plaintiffs and the public at large, her and her husband's financial gain and net worth would have plummeted, since Dr. Margaret A. Hamburg's husband, Peter F. Brown, reaped and continues to reap huge financial gain as a result of Renaissance Technologies, L.L.C.'s holdings of Johnson & Johnson stock.

To further this conspiracy, Dr. Margaret A. Hamburg, acting in concert with each and every Defendant, jointly and severally, appointed officials of Johnson & Johnson to key FDA Advisory Committees and colluded with Johnson & Johnson and its officials and subsidiaries to suppress information about the dangerous and deadly effects of Levaquin. As a result, during Dr. Margaret A. Hamburg's tenure as FDA Commissioner from 2009 to 2015, over 5,000 people died as a result of consuming Levaquin and other dangerous drugs promoted, manufactured, marketed, distributed and sold by Johnson & Johnson, suffered debilitating, life-threatening, and deadly illnesses and effects. This deadly harm is continuing as Plaintiffs and thousands of other people are suffering and dying from the highly dangerous effects of Levaquin.

Because of the Defendants' racketeering scheme and conspiracy to suppress warnings and other material information about the extent of the deadly effects of Levaquin, Plaintiffs were precluded from discovering the extent of their injuries until 2015, not coincidentally after Dr. Margaret A. Hamburg no longer held her position as FDA Commissioner in 2015 and material information about the full extent of the dangers of Levaquin were disclosed thereafter.

Defendants, each and every one of them, profited handsomely from their racketeering conspiracy by their agreed-upon failure to disclose the harmful effects of Levaquin to Plaintiffs and the public at large. This case is thus of seminal importance not only for Plaintiffs, but also for the consuming public at large. It is a tragic testament to how corrupt companies like Johnson & Johnson and their officials bribe and illegally collude with government officials and line their pockets at the expense of persons such as Plaintiffs.

Defendant Hamburg, on behalf of all of the Defendants as part of this racketeering conspiracy, gave political contributions and gratuities to Hillary Clinton in 2005, 2006, 2007, and 2008 to induce Mrs. Clinton to recommend and push for Defendant Hamburg to be nominated by President Obama.

Defendant Hamburg, on behalf of all of the Defendants as part of this racketeering conspiracy, gave political contributions and gratuities to President Obama to induce him to nominate her to be appointed as FDA Commissioner.

In and around May 26, 2009, Defendant Hamburg was forced to divest herself of several hedge fund holdings, as was her husband, Defendant Brown. This was done in order for her to take the position as the top food and drug regulator without any real or apparent conflicts of interest. However, the conflict of interest herein was never resolved. Neither Defendant Hamburg nor Defendant Brown, nor any other Renaissance Technologies executive had fully disclosed to Congress and other authorities that Defendant Brown, Defendant Hamburg's husband at all material times, still held shares in – and benefits financially from – all of the stocks of Renaissance, via Renaissance Technologies profit-sharing, as explained in detail by Defendant Simons, regardless of whether Defendant Brown divested himself of a particular hedge fund, in furtherance of the racketeering enterprise and conspiracy.

While Defendant Hamburg was FDA Commissioner, her husband, Defendant Brown's annual income, not coincidentally, increased from a reported $10 million in 2008 to an estimated $125 million in 2011 and an estimated $90 million in 2012, due in whole or in part to Defendants' racketeering conspiracy to withhold information about the devastating, life threatening, and deadly effects of Levaquin.

As part of Defendant Hamburg's pattern and practice of acting illegally outside of the scope of her authority as FDA Commissioner in furtherance of the racketeering enterprise and conspiracy, she counseled the FDA to also approved another highly dangerous pharmaceutical drug that Renaissance Technologies owns stock in, Zohydro, despite the fact that on December 7, 2012, an FDA Advisory Committee voted 11 to 2 against its approval. In or around March 2013, Defendant Hamburg personally testified to members of Congress that she supported Zohydro's approval.

Defendant Hamburg, as part of her pattern and practice of illegally acting outside the scope of her authority as Commissioner of the FDA, fraudulently used the U.S. mails and wires to commit overt acts in furtherance of the racketeering enterprise and conspiracy by willfully and intentionally and illegally preventing the FDA from issuing warnings about the devastating and life-threatening effects of Levaquin.

On November 5, 2015, after Defendant Hamburg had resigned, an FDA employee, Debra Boxwell, finally exposed to Plaintiffs, and the public at large, that Defendant Hamburg and the FDA had been aware that Levaquin may result in multi-system disability since 2013, but that it did nothing to add this information to the Levaquin label and instead conspired with the other Defendants to fraudulently withhold it.

From May 2009 to March 2015, Plaintiffs suffered mitochondrial toxicity, neuropsychiatric adverse events, and multi-system disability related to their consumption of Levaquin, including a constellation of medical issues related to the following body systems: neuromuscular, neuropsychiatric, peripheral neuropathy, senses, skin, cardiovascular, plus, endocrine, nutritional, metabolic and immunity; blood and blood forming organs; circulatory system; respiratory system; digestive system; genitourinary system; and connective tissue.

Specifically, Plaintiffs suffer from a constellation of medical issues, including but not limited to widespread bodily pain, fatigue, muscle weakness, muscle twitching, muscle wasting, gait disturbances, severe balance issues, stiffness, spasms, joint pain, tendon issues, seizures, tremors, numbness, burning, tingling, fasciculation, spasticity, nerve damage, autonomic issues, voice issues, exercise intolerance, difficulty swallowing, slow digestive motility, abdominal pain, acid reflux, gastritis, nausea, constipation, diarrhea, colitis, cognitive impairment, memory impairment, cardiac issues, urinary issues, kidney damage, liver damage, pancreatic damage, thyroid abnormalities, hair loss, glucose issues, respiratory issues, emotional issues, depression, psychosis, depersonalization, dissociation, anxiety, insomnia, abnormal dreams, suicidal thoughts, thought alterations, agitation, fatigue, dizziness, inability to concentrate, panic attacks, difficulty communicating, forgetfulness, bruising, vision issues, hearing issues, tinnitus, dental issues, gum issues, skin issues, rashes, multiple chemical sensitivity, sexual dysfunction, reproductive issues, and DNA damage.

Defendants, each and every one of them, operated a criminal conspiracy at least between the years 2009 to 2015 to fraudulently suppress warnings about the devastating effects of Levaquin.

Specifically, the purpose of Defendants' racketeering enterprise included, but was not limited to, reaping large financial gain by willfully and intentionally suppressing material information, through the fraudulent use of the U.S. mails and wires, about the devastating, life threatening, and deadly effects of Levaquin. These Defendants form this association in fact for the common and continuing purpose described herein and constitute an enterprise within the meaning of 18 U.S.C. SS 1961(4) engaged in the conduct of their affairs through a continuing pattern of racketeering activity. As described in the foregoing paragraphs of this Amended Complaint, Defendants, each and every one of them, maintained an ongoing relationship during the course of their ongoing criminal enterprise.

PREDICATE ACTS Bribery in Violation of 18 U.S.C. SS 201, Predicate Act No. 1
From May 2009 to March 2015, Defendants Johnson & Johnson, Johnson & Johnson PRD, and Janssen committed acts constituting indictable offenses under 18 U.S.C. SS 201(b)(1)(A)-(C) in that they directly or indirectly, corruptly gave, and offered and promised things of valuable, such as money, to Defendant Hamburg, who for the purposes of this predicate act was a public official as FDA Commissioner, with the intent to influence Defendant Hamburg to suppress material information about the devastating, life-threatening, and deadly effects of Levaquin. This is evidenced by Defendants Johnson & Johnson, Johnson & Johnson PRD, and Janssen's pattern and practice of using gratuities and bribery to secure favorable treatment for its products, as described in paragraph 40 of this Amended Complaint. 109.

Predicate Act No. 19
From May 2009 to March 2015, Defendants Renaissance Technologies, Brown, Mercer, and Simons, in furtherance of the racketeering enterprise and conspiracy, transferred ill-gotten and illegal financial gains from Defendant Renaissance Technologies' holdings of Defendant Johnson & Johnson stock to Defendants in order to continue to carry out Defendants unlawful conspiracy to conceal material information about the devastating and life-threatening effects of Levaquin.

As set forth previously, in every quarter except one, from May 2009 to March 2015, while Defendant Hamburg was FDA Commissioner, her husband, Defendant Brown's employer, Defendant Renaissance Technologies, held significant amounts of Defendant Johnson & Johnson stock, including as much as half a billion dollars in Defendant Johnson & Johnson stock.

Learn more: naturalnews.com/053767_Margaret_Hamburg_FDA_commissioner_conspiracy_and_racketeering.html#ixzz46jLoQS8Y

Posted by
Anonymous
on
I WAS TOLD THAT TVT MESH SURGEY WAS AN EASY OUPATIENT SURGERY NO WORRIES. IT WOULD FIX MY PROLAPSE AND I WOULD NOT HAVE ANY INCONTINCE ISSUES. A SIMPLE PROCEDURE WITH MANY EXCELLENT OUTCOMES. MY OB GYN WAS EXCITEDLY EXPLAINING TO MY HUSBAND AND I HOW EASY IT WOULD BE. SHE EVEN GAVE ME OTHERS WHO HAD PROCEDURE DONE FOR REFERRENCE. SO I HAD CALLED THE PHONE LIST SHE GAVE ME. THEY WERE SUCCESSFUL SURGERY PATIENTS ALSO I WAS GIVEN A PAMPHLET WITH INFORMATION . ALL SEEMED GOOD. I EVEN LOOKED UP ONLINE INFORMATION FROMTHER WEB SITE. NOTHING TROUBLING THERE. WORSE MISTAKE I EVER MADE. SHORTLY AFTER SURGEY THE INCONTINECE WAS WORSE MY BLADDER FELL AND I WAS RETAINING URINE. I BECAME ILL.SEEN OB FOR YEARLY CHECK I HAD TO CATH MYSELF DAILY.SHE GAVE ME A NAME OF A SURGEON. BY THEN I WAS IN EXCRUTIATING PAIN WENT TO ER THEY THOUGHT GROIN PULL. NO-THE MESH HAD WRAPPED AROUND MY PUBIC BONE I COULD BARELY WALK.I STILL WORKED I HAD TO. THEY UNDERSTOOD FOR I WORKED AT A DOCTORS OFFICE.SELF CATHING DAILY IN PUBLIC BATHROOM I HAD MANY INFECTIONS.I CRIED DAILY IT WAS HARD THING TO DO.IT WAS SO PAINFUL SO EMBARISING.I COULDNT SEE SURGEON FOR 2 MOS.EXTREMELY BOOKED.I THOUGHT I WOULD DIE. FINALLY SEEN HIM RAN TESTS.MY BLADDER WAS BEING CUT IN 2 THE MESH WAS KINKING UP AND I COULD NOT URINATE. SURGERY WAS DONE. I FELT SOME WHAT BETTER BUT STILL HAD SEVERVE PAIN IN PUBIC AREA. NOT ABLE TO HAVE SEX SINCE BEFORE TVT WAS 1 ST PUT IN.I COULDNT EVEN HARDLY WIPE W/OUT PAIN.I WAS RETAING URINE AND STILL NEEDED ANOTHER SURGEY. SO SLING RELEASED NO HELP . RE DID TESTING. STILL RETAING URINE.WHEN YOU RETAIN URINE IT MAKES YOU PHYSICALLY ILL. I WAS IN HORRIBLE SHAPE.I WANTED TO DIE.IT WAS HRD TO WORK I CRIED ALL THE TIME. MY FAMILY COULD ONLY WATCH ME IN HORROR.SO ANOTHER SURGERY DONE RIGHT BEFOE SURGERY I ASKED PLEASE LOOK AROUND AND SEE IF THERE IS MESH FROM 1ST SUREGY STILL THERE. LOW AND BEHOLD THERE WAS. IT WAS WRAPPED AROUND PUBIC BONE.AFTER REMOVING IT NO MORE PRESSURE. BUT NOW I HAVE PAIN IN ANOTHER AREA. TESTING AGAIN CANT FIND OUT WHY PAIN IS THERE.MY POOR HUSBAND ITS BEEN NIGHT MARE FOR US BOTH. MY VACTIONS HAVE BEEN OPERATION/RECOVERIES.IM AN EMOTIONAL MESS I CRY ALOT AND ITS HARD TO BE INTIMATE.I FEEL SO VIOLATED.

ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Gynecare Mesh Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Receive our weekly newsletter with the latest lawsuit news and legal information.
Sponsored by:
National Center for Life and Liberty
Advertisement


Related Lawsuits

Legal Services:

Advertisement
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com